IndexIQ Advisors’s Intersect ENT, Inc XENT Stock Holding History

IndexIQ Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.2M	Sell	78,631 -11,701	-13%	-$321K	0.08%	220
2021 Q4	$2.47M	Sell	90,332 -4,375	-5%	-$119K	0.08%	208
2021 Q3	$2.58M	Buy	+94,707	New	+$2.34M	0.09%	208
2021 Q1	–	Sell	-17,675	Closed	-$405K	–	1369
2020 Q4	$405K	Buy	17,675 +1,825	+12%	+$34.7K	0.01%	490
2020 Q3	$259K	Buy	15,850 +859	+6%	+$15.6K	0.01%	477
2020 Q2	$203K	Sell	14,991 -1,081	-7%	-$12.6K	0.01%	566
2020 Q1	$190K	Buy	+16,072	New	+$356K	0.01%	440

Other funds holding XENT

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAM

Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IndexIQ Advisors's XENT Position: Q1 2022 in Review

IndexIQ Advisors reduced its Intersect ENT, Inc (XENT) stake by 13% in Q1 2022, selling an estimated $321K and leaving 78,631 shares worth $2.2M. The position accounts for 0.08% of the portfolio, ranked #220.

IndexIQ Advisors first reported a position in XENT in Q1 2020 and has held it in 7 quarters since. The position peaked at $2.58M in Q3 2021. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

IndexIQ Advisors held 78,631 shares of Intersect ENT, Inc worth $2.2M as of Q1 2022.
IndexIQ Advisors sold 11,701 Intersect ENT, Inc shares in Q1 2022, an estimated $321K.
Intersect ENT, Inc made up 0.08% of IndexIQ Advisors's portfolio in Q1 2022, its #220 holding.
IndexIQ Advisors first reported a position in Intersect ENT, Inc in Q1 2020 and has held it in 7 quarters since.
IndexIQ Advisors's Intersect ENT, Inc position peaked at $2.58M in Q3 2021.
131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.